Copy number of cancer genes predict tumor grade and survival of pancreatic cancer patients

Anticancer Research

Volumn 21, Issue 2 B, 2001, Pages 1321-1326

  Nagy, A ^a   Kozma, L ^a   Kiss, I ^a   Ember, I ^a   Takacs, I ^a   Hajdu, J ^a   Farid, N R ^a  

^a Osancor Biotech Inc   (United Kingdom)

Author keywords

C myc; Gene copy number; K ras; Logistic regression analysis; p53; Survival; Tumor grade

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE AMPLIFICATION; HUMAN; MALE; ONCOGENE C MYC; ONCOGENE K RAS; PANCREAS CANCER; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; FEMALE; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS P21(RAS); RISK FACTORS; SURVIVORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035011374     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The molecular and cellular biology of pancreatic cancer
2. Smoking, alcohol, coffee and tea intake and the incidence of cancer of the exocrine pancreas: The Iowa Women's Health Study Cancer Epidemiol
3. Fish consumption and cancer risk
4. Green tea consumption and the risk of pancreatic and colorectal cancers
5. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma
6. Genetics of pancreatic cancer. From genes to families
7. Molecular oncology in pancreatic cancer
8. Molecular diagnosis of pancreas carcinoma
9. Histological and fine structural features of pancreatic ductal adenocarcinoma in relation to growth and prognosis: Studies in xenografled tumors and clinico-pathological correlation in a series of 75 patients
10. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue
11. Differential expression of the normal and the transocated human c-myc oncogenes in B cells
12. Characterization of a human colon/lung carcinoma oncogene
13. Ban II and Sca I RFLP at the human p53 gene locus
14. Investigation of c-myc and K-ras amplification in renal cell adenocarcinoma
15. Microsatellite alterations at chromosomes 9p, 13q and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder
16. Prognostic significance of molecular alterations in pancreatic carcinoma - An immunohistological study
17. p53 independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma
18. p53, the cellular gatekeeper for growth and division
19. Allelotype of pancreatic adenocarcinoma using xenograft enrichment
20. Sensitive detection of loss of heterozygosity in the TP53 gene in pancreatic, adenocarcinoma by flourescence-based single-strand conformation polymorphism analysis using blunt-end DNA fragments genes
21. Utility of fluorescence in situ hybridization in pancreatic ductal carcinoma
22. Abnormalities of the p53 tumor suppressor gene in human pancreatic Cancer
23. Structural alteration of p53 protein correlated to survival in patients with pancreatic adenocarcinoma
24. WAF1/CIP1 functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential
25. Inhibition of pancreatic tumor cell growth in culture by p21Wafl recombinant adenovirus
26. The clinical significance of p21 WAF1/CIP1 and p53 expression in pancreatic adenocarcinoma
27. Common patterns of genetic evolution in human solid tumors
28. C-myc overexpression and p53 loss cooperate to promote genomic instability
29. Predisposition to neoplastic transformation caused by gene replacement of H-ras 1
30. Essential role for oncogenic Ras in tumour maintenance
31. p53 expression affects the efficacy of adjuvant chemotherapy after resection of invasive ductal carcinoma of the pancreas
32. Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy
33. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy